57 related articles for article (PubMed ID: 17643815)
21. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
22. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
23. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
Chen F; Zhang G; Cao Y; Payne R; See WA
J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
[TBL] [Abstract][Full Text] [Related]
24. Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs.
Wang D; Wang Z; Tian B; Li X; Li S; Tian Y
Int J Urol; 2008 May; 15(5):435-41. PubMed ID: 18452462
[TBL] [Abstract][Full Text] [Related]
25. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
[TBL] [Abstract][Full Text] [Related]
26. [The heat shock protein 70 antisense oligomers enhance the sensitivity of bladder cancer cell EJ to mitomycin C].
He LF; Hou SK; Yan Z; Ren L; Wang SW
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1108-10. PubMed ID: 15498297
[TBL] [Abstract][Full Text] [Related]
27. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
28. Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.
Metselaar DS; Meel MH; Benedict B; Waranecki P; Koster J; Kaspers GJL; Hulleman E
EBioMedicine; 2019 Dec; 50():81-92. PubMed ID: 31735550
[TBL] [Abstract][Full Text] [Related]
29. The Fanconi family adds a fraternal twin.
Grompe M; van de Vrugt H
Dev Cell; 2007 May; 12(5):661-2. PubMed ID: 17488615
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of dehydroascorbic acid and mixtures with vitamin E and beta-carotene on mitomycin C efficiency under irradiation in vitro.
Kammerer C; Getoff N
In Vivo; 2004; 18(6):795-8. PubMed ID: 15646822
[TBL] [Abstract][Full Text] [Related]
31. Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited.
Howlett NG
Eur J Hum Genet; 2007 Jul; 15(7):715-7. PubMed ID: 17505525
[No Abstract] [Full Text] [Related]
32. Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.
Rudland PS; Platt-Higgins AM; Davies LM; de Silva Rudland S; Wilson JB; Aladwani A; Winstanley JH; Barraclough DL; Barraclough R; West CR; Jones NJ
Am J Pathol; 2010 Jun; 176(6):2935-47. PubMed ID: 20363922
[TBL] [Abstract][Full Text] [Related]
33. Mitomycin C: a clinical update.
Bradner WT
Cancer Treat Rev; 2001 Feb; 27(1):35-50. PubMed ID: 11237776
[TBL] [Abstract][Full Text] [Related]
34. Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.
Shinde A; Berhane H; Rhieu BH; Kalash R; Xu K; Goff J; Epperly MW; Franicola D; Zhang X; Dixon T; Shields D; Wang H; Wipf P; Parmar K; Guinan E; Kagan V; Tyurin V; Ferris RL; Zhang X; Li S; Greenberger JS
Radiat Res; 2016 Feb; 185(2):134-50. PubMed ID: 26789701
[TBL] [Abstract][Full Text] [Related]
35. mTOR kinase inhibitor sensitizes T-cell lymphoblastic leukemia for chemotherapy-induced DNA damage via suppressing FANCD2 expression.
Guo F; Li J; Zhang S; Du W; Amarachintha S; Sipple J; Phelan J; Grimes HL; Zheng Y; Pang Q
Leukemia; 2014 Jan; 28(1):203-6. PubMed ID: 23852546
[No Abstract] [Full Text] [Related]
36. Helq acts in parallel to Fancc to suppress replication-associated genome instability.
Luebben SW; Kawabata T; Akre MK; Lee WL; Johnson CS; O'Sullivan MG; Shima N
Nucleic Acids Res; 2013 Dec; 41(22):10283-97. PubMed ID: 24005041
[TBL] [Abstract][Full Text] [Related]
37. Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway.
Lin HH; Zeng WH; Yang HK; Huang LS; Pan R; Lei NX
BMC Womens Health; 2024 Jan; 24(1):41. PubMed ID: 38218826
[TBL] [Abstract][Full Text] [Related]
38. The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy.
Du X; Song H; Shen N; Hua R; Yang G
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810518
[TBL] [Abstract][Full Text] [Related]
39. Expression of FANCD2 is associated with prognosis in patients with nasopharyngeal carcinoma.
Xu S; Zhao F; Liang Z; Feng H; Bao Y; Xu W; Zhao C; Qin G
Int J Clin Exp Pathol; 2019; 12(9):3465-3473. PubMed ID: 31934192
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer.
Feng L; Jin F
Oncol Lett; 2019 Apr; 17(4):3687-3700. PubMed ID: 30881493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
